Top compounds associated with response to ILVBL


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.00041 1
mRNA Tamoxifen CTRPv2 pan-cancer AAC 0.00044 1
mRNA paclitaxel CCLE pan-cancer AAC 0.00052 1
mRNA Vorinostat CTRPv2 pan-cancer AAC -0.00016 1
mRNA AZD6244 FIMM pan-cancer AAC -0.00076 1
mRNA LY-2157299 CTRPv2 pan-cancer AAC 0.00011 1
Download CSV